Biomarkers for Chronic Pain: Significance and Summary of Recent Advances

Overview

Journal Pain Res Manag

Date 2022 Nov 17

PMID 36385904

Authors

Sam Eldabe

Ilona Obara

Catherine Panwar

David Caraway

Affiliations

Soon will be listed here.

Abstract

Chronic pain can be difficult to predict and a challenge to treat. Biomarkers for chronic pain signal an opportunity for advancements in both management and prevention, and through their research and development offer new insights into the complex processes at play. This review considers the latest research in chronic pain biomarker development and considers how close we are to bringing these from bench to bedside. While some headway has been made that offers efficiencies in patient selection, it is unlikely that a single test will encompass the variety of chronic pain phenotypes. We offer some insights for the near future in biomarker development and areas of continued unmet need.

Citing Articles

Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.

Belitzky E, Ravani Carvalho L, Taylor M, Ortiz C, Baum L, Fiellin D Cancer Med. 2025; 14(5):e70586.

PMID: 40052631 PMC: 11886891. DOI: 10.1002/cam4.70586.

Predicting Individual Pain Sensitivity Using a Novel Cortical Biomarker Signature.

Chowdhury N, Bi C, Furman A, Chiang A, Skippen P, Si E JAMA Neurol. 2025; 82(3):237-246.

PMID: 39869323 PMC: 11773403. DOI: 10.1001/jamaneurol.2024.4857.

A novel cortical biomarker signature predicts individual pain sensitivity.

Chowdhury N, Bi C, Furman A, Chiang A, Skippen P, Si E medRxiv. 2024; .

PMID: 39399054 PMC: 11469350. DOI: 10.1101/2024.06.16.24309005.

Effect of neuromodulation for chronic pain on the autonomic nervous system: a systematic review.

Billet B, Goudman L, Rigoard P, Billot M, Roulaud M, Verstraete S BJA Open. 2024; 11:100305.

PMID: 39319097 PMC: 11419894. DOI: 10.1016/j.bjao.2024.100305.

Cardiac sensing at a spinal cord stimulation lead: a promising on-device potential biomarker for pain and wellbeing.

Brinda A, Goudman L, Moens M, Hincapie J, Dinsmoor D, Litvak L Front Physiol. 2024; 15:1342983.

PMID: 39189030 PMC: 11345370. DOI: 10.3389/fphys.2024.1342983.

References

Fayaz A, Croft P, Langford R, Donaldson L, Jones G . Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open. 2016; 6(6):e010364. PMC: 4932255. DOI: 10.1136/bmjopen-2015-010364. View

Gunn J, Hill M, Cotten B, Deer T . An Analysis of Biomarkers in Patients with Chronic Pain. Pain Physician. 2020; 23(1):E41-E49. View

Zhang Z, Gewandter J, Geha P . Brain Imaging Biomarkers for Chronic Pain. Front Neurol. 2022; 12:734821. PMC: 8763372. DOI: 10.3389/fneur.2021.734821. View

. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1211-1259. PMC: 5605509. DOI: 10.1016/S0140-6736(17)32154-2. View

Nwagwu C, Sarris C, Tao Y, Mammis A . Biomarkers for Chronic Neuropathic Pain and their Potential Application in Spinal Cord Stimulation: A Review. Transl Perioper Pain Med. 2017; 1(3):33-38. PMC: 5415348. View

Tracey I, Woolf C, Andrews N . Composite Pain Biomarker Signatures for Objective Assessment and Effective Treatment. Neuron. 2019; 101(5):783-800. PMC: 6800055. DOI: 10.1016/j.neuron.2019.02.019. View

Kuijpers T, van Middelkoop M, Rubinstein S, Ostelo R, Verhagen A, Koes B . A systematic review on the effectiveness of pharmacological interventions for chronic non-specific low-back pain. Eur Spine J. 2010; 20(1):40-50. PMC: 3036024. DOI: 10.1007/s00586-010-1541-4. View

Claret P, Bobbia X, Roger C, Sebbane M, de la Coussaye J . Review of point-of-care testing and biomarkers of cardiovascular diseases in emergency and prehospital medicine. Acta Cardiol. 2015; 70(5):510-5. DOI: 10.2143/AC.70.5.3110510. View

Davis K, Aghaeepour N, Ahn A, Angst M, Borsook D, Brenton A . Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities. Nat Rev Neurol. 2020; 16(7):381-400. PMC: 7326705. DOI: 10.1038/s41582-020-0362-2. View

10.

Deer T, Caraway D, Wallace M . A definition of refractory pain to help determine suitability for device implantation. Neuromodulation. 2014; 17(8):711-5. DOI: 10.1111/ner.12263. View

11.

Amirdelfan K, Pope J, Gunn J, Hill M, Cotten B, Beresh J . Clinical Validation of a Multi-Biomarker Assay for the Evaluation of Chronic Pain Patients in a Cross-Sectional, Observational Study. Pain Ther. 2020; 9(2):511-529. PMC: 7648807. DOI: 10.1007/s40122-020-00175-3. View

12.

Telkes L, Hancu M, Paniccioli S, Grey R, Briotte M, McCarthy K . Differences in EEG patterns between tonic and high frequency spinal cord stimulation in chronic pain patients. Clin Neurophysiol. 2020; 131(8):1731-1740. DOI: 10.1016/j.clinph.2020.03.040. View

13.

van der Miesen M, Lindquist M, Wager T . Neuroimaging-based biomarkers for pain: state of the field and current directions. Pain Rep. 2019; 4(4):e751. PMC: 6727991. DOI: 10.1097/PR9.0000000000000751. View

14.

Kawi J, Lukkahatai N, Inouye J, Thomason D, Connelly K . Effects of Exercise on Select Biomarkers and Associated Outcomes in Chronic Pain Conditions: Systematic Review. Biol Res Nurs. 2015; 18(2):147-59. DOI: 10.1177/1099800415599252. View

15.

Yong R, Mullins P, Bhattacharyya N . Prevalence of chronic pain among adults in the United States. Pain. 2021; 163(2):e328-e332. DOI: 10.1097/j.pain.0000000000002291. View

16.

Almeida M, Saragiotto B, Richards B, Maher C . Primary care management of non-specific low back pain: key messages from recent clinical guidelines. Med J Aust. 2018; 208(6):272-275. DOI: 10.5694/mja17.01152. View

17.

Qaseem A, Wilt T, McLean R, Forciea M, Denberg T, Barry M . Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2017; 166(7):514-530. DOI: 10.7326/M16-2367. View

18.

Andersson G . Epidemiological features of chronic low-back pain. Lancet. 1999; 354(9178):581-5. DOI: 10.1016/S0140-6736(99)01312-4. View

19.

Chou R, Qaseem A, Snow V, Casey D, Cross Jr J, Shekelle P . Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007; 147(7):478-91. DOI: 10.7326/0003-4819-147-7-200710020-00006. View

20.

Cohen S, Deyo R . A call to arms: the credibility gap in interventional pain medicine and recommendations for future research. Pain Med. 2013; 14(9):1280-3. DOI: 10.1111/pme.12186. View